Steve Harshbarger
Analyst · Colliers. Please go ahead
Thanks, Steve, and good morning, everybody. I appreciate you all taking the time to listen to our call today. If you look at our Q2 earnings release that was put out this morning, you'll see in the short tables on the last page that we break down our sales in three ways; by markets, products, geography, and that's how I'm going to talk about them this morning. Fiscal second quarter net sales were 4,070,000, which is up 17% or nearly 600,000, and that's in comparison to the second quarter of last year. By product line, the second quarter sales increase was primarily driven by a significant shipment of multi-axis coating systems. The systems shipped with this order are now being used to coat electronic diagnostic devices for rapid COVID test kits. Our OEM sales were up 613,000 or 264%, and this was due to strong sales from our OEM semiconductor partners and as well as our OEM PCB fluxing partners. Looking at the market segments, sales to the electronics market increased by 79% in Q2. This was primarily driven by strong sales to China for our OEM systems used in the semiconductor market, as well as those systems that I just mentioned to quote the electronic diagnostic devices for rapid COVID test kits. The alternative energy market was also strong for us. We continue to see growing investments in the clean energy sector from both government as well as private industry that are driving demand for our machines used for coating membranes and fuel cells, as well as carbon capture applications. By geography, approximately 62% of our sales originated outside of the U.S. and Canada compared with 38% in last year’s second quarter. These strong overseas sales were primarily driven from APAC and that was led by China, which reflects the transition to several countries as well as companies emerging from COVID-19 lockdowns and bringing the manufacturing operations really back online. Shipments to China during the second quarter included strong sales for our stent coating machines, the delivery of a newly developed specialty medical device coding system, and another follow-on strong quarter for our OEM semiconductor customers. Looking at APAC outside of China, sales included a new machine that shipped to Singapore for EMI coating, electromagnetic emission coating and which is an area we've spoken about several times as part of our focus growth initiatives. As well as we had a repeat order for our latest balloon catheter coating machine that was shipped to Japan. Sales to the U.S. and Canada did dip year-over-year, and this is primarily due to the shipment of a large float glass coating line in last year's Q2, which we didn't repeat in Q2 of this year. This isn’t unusual because sales of these large industrial float glass coding machines typically vary from period to period. There was also a large order from the advanced energy market in last year's Q2 that didn't repeat in the current period. Throughout the COVID pandemic, Sono-Tek's really been adapting and refocusing our sales efforts to those countries that are most operational during these COVID-19 peaks and dips. This strategy has been really helpful to us in softening the impact of the pandemic on our operations, and we expect the sales packet [ph] to be part of Sono-Tek's go-to-market strategy for the foreseeable future here. Backlog reached a company high record of 6,332,000 at the end of our second quarter. This is an increase of 45% from the end of the first quarter, an increase of 64% compared to the end of fiscal 2021 six months ago. We believe this growth is really directly related to our expanding product line and the increasing activity of our application development laboratories. Our network of labs located at Sono-Tek distributor sites around the globe and our home base here in New York, of course, are staffed with highly experienced application engineers that work together with our customers to develop solutions for their next generation accorded products. These labs are an important advantage for Sono-Tek, and they really separate us from others. In closing, Sono-Tek has a lot of momentum and a strong outlook. And we're excited about our opportunities for growth in our focus markets of semiconductor, medical and clean energy. Looking ahead, the sales growth guidance for the back half of our fiscal year is for double digit increases over the comparable periods of last year for both the third as well as the fourth quarters. And for the fiscal year, which will be ending now February 28, 2022, Sono-Tek is expecting double digit year-over-year growth, which will be our highest annual sales in corporate history. So this concludes the formal part of our presentation. And we now like to open up the call for questions, and I'll send it back over to the operator.